| “Possible LNB” (n = 44) | “Not determined” (n = 55) |
Age, years, median (range) | 7 (1 - 18) | 12 (2 - 18) |
Male, n (%) | 20 (45) | 26 (47) |
Known tick bite, n (%) | 26 (59) | 31 (56) |
Duration of symptoms, n (%) |
|
|
<1 week | 26 (59) | 21 (38) |
1 - 4 weeks | 16 (36) | 15 (27) |
1 - 2 months | 2 (5) | 8 (15) |
>2 months | 0 (0) | 11 (20) |
Major clinical manifestations, n (%)a |
|
|
Facial nerve palsy | 34 (77) | 20 (36) |
Headache | 26 (59) | 40 (73) |
Meningitis, subacute | 20 (45) | 6 (11) |
EM and/or lymfocytoma | 23 (52) | 3 (5) |
Laboratory findings, n (%) |
|
|
Pleocytosis in CSF, median (range)b | 68 (5 - 575) | 1 (0 - 4) |
Anti-Borrelia antibodies in CSF, n (%)c | 0 (0) | 0 (0)
|
Anti-Borrelia antibodies in serum, n (%)d |
|
|
Anti-IgM | 12 (27) | 6 (11) |
Anti-IgG | 3 (7) | 2 (4) |
Anti-IgM and IgG | 9 (20) | 6 (11) |
Antibiotic treatment, n (%) |
|
|
Ceftriaxone, iv | 21 (48) | 0 (0) |
Doxycycline, po | 23 (52) | 3 (5) |